Todd Lynch Joins BioAgilytix Labs As SVP And Chief Financial Officer

DURHAM, N.C.--(BUSINESS WIRE)--BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Todd Lynch, CPA to its executive leadership team as SVP and Chief Financial Officer. With more than 23 years of experience in biotechnology, big pharma, clinical diagnostics, and contract research organizations ranging from pre-revenue to Fortune 500 companies, Mr. Lynch will play a key role in the development and execution of strategies to support BioAgilytix's rapid growth.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

The agreement gives Biogen rights to a drug that is closing in on data from three late-phase trials that will shape its future.

The U.K. government has asked the national regulator to consider clearing AstraZeneca’s COVID-19 vaccine for temporary supply when it receives data.

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.